The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Infect Dis Clin North Am
; 21(1): 219-39, x, 2007 Mar.
Article
en En
| MEDLINE
| ID: mdl-17502237
ABSTRACT
Topical microbicides are self-administered products for prevention of HIV transmission, and they present one of the most promising strategies for combating the HIV-AIDS epidemic. The development of microbicides is a long and complicated process, with many hurdles that are unique to this class of product, including challenges in product design, in the conduct and design of clinical trials, and in obtaining licensure of a new class of products intended for use almost exclusively in developing countries. Once they have been registered, there are additional challenges to the marketing and distribution of microbicides. An overview of the types of microbicide currently in development, and a summary of the issues and the approaches being taken to address them, are provided.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Infecciones por VIH
/
Fármacos Anti-VIH
/
Antiinfecciosos Locales
Límite:
Humans
Idioma:
En
Año:
2007
Tipo del documento:
Article